The U.S. International Trade Commission ruled that the Altria-owned company’s vaping devices violate four of Juul’s patents.

BofA Securities made an adjustment to the price target for Altria stock, bringing it down to $61 from the previous $65, while still maintaining a Buy rating on the shares. This change was announced by ...

Yet Altria still leads the cigarette market by a wide margin, its profits are solid, and its dividend that yields 8% annually ...

Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out ...

Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been ...

The U.S. Food and Drug Administration (FDA) has approved Celltrion’s AVTOZMA (CT-P47, tocilizumab-anoh) in both an ...

Tech titans Amazon and Meta each contributed $1 million to Trump’s inaugural committee. The companies’ respective founders, ...

By Sarah Ladd Kentucky Lantern The American Lung Association gave Kentucky mostly failing grades when it comes to preventing tobacco use — and helping people access recovery — in a 2025 report ...

Biden faces backlash for failing to ban menthol cigarettes, sparking public health concerns and debate over tobacco industry ...

Altria Group Inc (MO) reports robust earnings growth and shareholder returns, while navigating the complexities of the ...

Marlboro maker Altria said on Thursday its annual adjusted profit could be lower than estimated, citing rising competition ...

Morgan Stanley lowered the firm’s price target on Altria Group (MO) to $53 from $54 and keeps an Equal Weight rating on the shares. Shares ...